Different Treatment Strategies on Prognosis of Acute Ischemic Stroke(AISDTS)

Recruiting now

Conditions studied: Ischemic Stroke

In brief

AISDTS is a prospective registry study, in which clinical information, examination and imaging data of patients with acute ischemic stroke receiving different treatment strategies were collected, grouped and statistically analyzed, and corresponding clinical prediction models were constructed to explore the role of clinical biological indicators in the occurrence and development of stroke.

Key facts

Study ID

NCT05410457

Run by

Nanjing First Hospital, Nanjing Medical University

People needed

5000

Starts

2022-05-24

Expected to finish

2027-06-24

Last updated by the study team

2026-04-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• A) ≥18 years of age; B) hospital admission for ischemic stroke; C) Signed informed consent.

You may not qualify if…

• A) patients with incomplete clinical information; B) hospitalization observation time less than 24 hours; C) recent trauma, severe inflammation, severe liver and kidney dysfunction, progressive malignance and other serious diseases; D) baseline mRS score>2; E) informed consent is not signed.

Where it is running

• Nanjing First Hospital, Nanjing Medical University — Nanjing, Jiangsu, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.